Final results of the DAPS (Denosumab Adherence Preference Satisfaction) study: a 24-month, randomized, crossover comparison with alendronate in postmenopausal women
N. Freemantle, S. Satram-Hoang, E.-T. Tang, P. Kaur, D. Macarios, S. Siddhanti, J. Borenstein, D. L. Kendler, on behalf of the DAPS InvestigatorsVolume:
23
Langue:
english
Pages:
10
DOI:
10.1007/s00198-011-1780-1
Date:
January, 2012
Fichier:
PDF, 349 KB
english, 2012
File converter
Plus de résultats de recherche
More benefits 
